{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:59:10Z","timestamp":1791849550698,"version":"4.3.4"},"reference-count":47,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej18-0477","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T22:02:57Z","timestamp":1560808977000},"page":"905-913","source":"Crossref","is-referenced-by-count":28,"title":["Platelet to lymphocyte ratio correlates with diabetic foot risk and foot ulcer in patients with type 2 diabetes"],"prefix":"10.1507","volume":"66","author":[{"given":"Yusuke","family":"Mineoka","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Otsu City Hospital, Otsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiyo","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Otsu City Hospital, Otsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Nursing, Otsu City Hospital, Otsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Saiseikai Kyoto Hospital, Nagaoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2337\/diacare.22.3.382","volume":"22","author":"SD Ramsey","year":"1999","unstructured":"1 Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, et al. (1999) Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22: 382\u2013387.","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"2","unstructured":"2 Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, et al. (2006) Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg 45: S1\u2013S66."},{"key":"3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","volume":"293","author":"N Singh","year":"2005","unstructured":"3 Singh N, Armstrong DG, Lipsky BA (2005) Preventing foot ulcers in patients with diabetes. JAMA 293: 217\u2013228.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4 Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, et al. (1999) Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22: 157\u2013162.","DOI":"10.2337\/diacare.22.1.157"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Crawford F, Inkster M, Kleijnen J, Fahey T (2007) Predicting foot ulcers in patients with diabetes: a systematic review and meta-analysis. QJM 100: 65\u201386.","DOI":"10.1093\/qjmed\/hcl140"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG (1998) Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 158: 157\u2013162.","DOI":"10.1001\/archinte.158.2.157"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7 Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, et al. (2000) Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 23: 606\u2013611.","DOI":"10.2337\/diacare.23.5.606"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Margolis DJ, Hofstad O, Feldman HI (2008) Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes. Diabetes Care 31: 1331\u20131336.","DOI":"10.2337\/dc07-2244"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Adler AI, Erqou S, Lima TA, Robinson AH (2010) Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus-review and meta-analysis. Diabetologia 53: 840\u2013849.","DOI":"10.1007\/s00125-009-1638-7"},{"key":"10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2337\/diacare.21.7.1071","volume":"21","author":"CA Abbott","year":"1998","unstructured":"10 Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ (1998) Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 21: 1071\u20131075.","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Bakker K, Apelqvist J, Lipsky BA, Van Netten JJ; International Working Group on the Diabetic Foot (2016) The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev 32 Suppl 1: 2\u20136.","DOI":"10.1002\/dmrr.2694"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12 Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, et al. (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 455\u2013461.","DOI":"10.2337\/diabetes.51.2.455"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Twig G, Afek A, Shamiss A, Derazne E, Tzur D, et al. (2013) White blood cells count and incidence of type 2 diabetes in young men. Diabetes Care 36: 276\u2013282.","DOI":"10.2337\/dc11-2298"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Zaccardi F, Rocca B, Pitocco D, Tanese L, Rizzi A, et al. (2015) Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis. Diabetes Metab Res Rev 31: 402\u2013410.","DOI":"10.1002\/dmrr.2625"},{"key":"15","unstructured":"15 Ozder A, Eker HH (2014) Investigation of mean platelet volume in patients with type 2 diabetes mellitus and in subjects with impaired fasting glucose: a cost-effective tool in primary health care? Int J Clin Exp Med 7: 2292\u20132297."},{"key":"16","unstructured":"16 Jabeen F, Fawwad A, Rizvi HA, Alvi F (2013) Role of platelet indices, glycemic control and hs-CRP in pathogenesis of vascular complications in type-2 diabetic patients. Pak J Med Sci 29: 152\u2013156."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T (2012) Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol 23: 265\u2013273.","DOI":"10.3802\/jgo.2012.23.4.265"},{"key":"18","unstructured":"18 Akbas EM, Demirtas L, Ozcicek A, Timuroglu A, Bakirci EM, et al. (2014) Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy. Int J Clin Exp Med 7: 1794\u20131801."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Turkmen K, Erdur FM, Ozcicek F, Ozcicek A, Akbas EM, et al. (2013) Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int 17: 391\u2013396.","DOI":"10.1111\/hdi.12040"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20 American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35 Suppl 1: S64\u2013S71.","DOI":"10.2337\/dc12-s064"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Lipsky BA, Arag\u00f3n-S\u00e1nchez J, Diggle M, Embil J, Kono S, et al. (2016) IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev 32 Suppl 1: 45\u201374.","DOI":"10.1002\/dmrr.2699"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Mineoka Y, Ishii M, Tsuji A, Komatsu Y, Katayama Y, et al. (2017) Relationship between limited joint mobility of the hand and diabetic foot risk in patients with type 2 diabetes. J Diabetes 9: 628\u2013633.","DOI":"10.1111\/1753-0407.12460"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Ndip A, Rutter MK, Vileikyte L, Vardhan A, Asari A, et al. (2010) Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease. Diabetes Care 33: 1811\u20131816.","DOI":"10.2337\/dc10-0255"},{"key":"24","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/dc05-2031","volume":"29","author":"EJ Boyko","year":"2006","unstructured":"24 Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ (2006) Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care 29: 1202\u20131207.","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Alexiadou K, Doupis J (2012) Management of diabetic foot ulcers. Diabetes Ther 3: 4.","DOI":"10.1007\/s13300-012-0004-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Yasuda H, Sanada M, Kitada K, Terashima T, Kim H, et al. (2007) Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract 77 Suppl 1: S178\u2013S183.","DOI":"10.1016\/j.diabres.2007.01.053"},{"key":"27","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2337\/dc08-9021","volume":"31","author":"AJ Boulton","year":"2008","unstructured":"27 Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, et al. (2008) Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 31: 1679\u20131685.","journal-title":"Diabetes Care","ISSN":"https:\/\/id.crossref.org\/issn\/0149-5992","issn-type":"print"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Mineoka Y, Fukui M, Tanaka M, Tomiyasu K, Akabame S, et al. (2012) Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus. Heart Vessels 27: 160\u2013165.","DOI":"10.1007\/s00380-011-0138-0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982\u2013992.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Hinchliffe RJ, Brownrigg JR, Apelqvist J, Boyko EJ, Fitridge R, et al. (2016) IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diabetes Metab Res Rev 32 Suppl 1: 37\u201344.","DOI":"10.1002\/dmrr.2698"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Markakis K, Bowling FL, Boulton AJ (2016) The diabetic foot in 2015: an overview. Diabetes Metab Res Rev 32 Suppl 1: 169\u2013178.","DOI":"10.1002\/dmrr.2740"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 American Diabetes Association (2015) (9) Microvascular complications and foot care. Diabetes Care 38 Suppl 1: S58\u2013S66.","DOI":"10.2337\/dc15-S012"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Lee CM, Chang CC, Pan MY, Chang CF, Chen MY (2014) Insufficient early detection of peripheral neurovasculopathy and associated factors in rural diabetes residents of Taiwan: a cross-sectional study. BMC Endocr Disord 14: 89.","DOI":"10.1186\/1472-6823-14-89"},{"key":"34","unstructured":"34 Gary T, Pichler M, Belaj K, Hafner F, Gerger A, et al. (2013) Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One 8: e67688."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Sunbul M, Gerin F, Durmus E, Kivrak T, Sari I, et al. (2014) Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper <i>versus<\/i> non-dipper hypertension. Clin Exp Hypertens 36: 217\u2013221.","DOI":"10.3109\/10641963.2013.804547"},{"key":"36","unstructured":"36 Demirtas L, Degirmenci H, Akbas EM, Ozcicek A, Timuroglu A, et al. (2015) Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes. Int J Clin Exp Med 8: 11420\u201311427."},{"key":"37","doi-asserted-by":"publisher","unstructured":"37 Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, et al. (2004) Prevalence of lower-extremity disease in the US adult population &gt;=40 years of age with and without diabetes: 1999\u20132000 national health and nutrition examination survey. Diabetes Care 27: 1591\u20131597.","DOI":"10.2337\/diacare.27.7.1591"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Yokoyama H, Araki SI, Kawai K, Yamazaki K, Tomonaga O, et al. (2018) Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46). BMJ Open Diabetes Res Care 6: e000521.","DOI":"10.1136\/bmjdrc-2018-000521"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Borissoff JI, Spronk HM, ten Cate H (2011) The hemostatic system as a modulator of atherosclerosis. N Engl J Med 364: 1746\u20131760.","DOI":"10.1056\/NEJMra1011670"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Langer HF, Gawaz M (2008) Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 99: 480\u2013486.","DOI":"10.1160\/TH07-11-0685"},{"key":"41","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/01.CIR.0000081765.88440.51","volume":"108","author":"H Koyama","year":"2003","unstructured":"41 Koyama H, Maeno T, Fukumoto S, Shoji T, Yamane T, et al. (2003) Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 108: 524\u2013529.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42 Shoji T, Koyama H, Fukumoto S, Maeno T, Yokoyama H, et al. (2006) Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis. Atherosclerosis 188: 190\u2013195.","DOI":"10.1016\/j.atherosclerosis.2005.10.034"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Bhutta H, Agha R, Wong J, Tang TY, Wilson YG, et al. (2011) Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovascular Surg 45: 227\u2013231.","DOI":"10.1177\/1538574410396590"},{"key":"44","unstructured":"44 Apelqvist J, Bakker K, van Houtum WH, Schaper NC; International Working Group on the Diabetic Foot (IWGDF) Editorial Board (2008) Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 24 Suppl 1: S181\u2013S187."},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Iwase M, Fujii H, Nakamura U, Ohkuma T, Ide H, et al. (2018) Incidence of diabetic foot ulcer in Japanese patients with type 2 diabetes mellitus: the Fukuoka diabetes registry. Diabetes Res Clin Pract 137: 183\u2013189.","DOI":"10.1016\/j.diabres.2018.01.020"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Lavery LA, Peters EJ, Armstrong DG (2008) What are the most effective interventions in preventing diabetic foot ulcers? Int Wound J 5: 425\u2013433.","DOI":"10.1111\/j.1742-481X.2007.00378.x"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, et al. (2019) SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet 393: 31\u201339.","DOI":"10.1016\/S0140-6736(18)32590-X"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/10\/66_EJ18-0477\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T03:42:17Z","timestamp":1572666137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/10\/66_EJ18-0477\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0477","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}